Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Exploring Trauma Plus (ET+) (ET+)

13 novembre 2026 mis à jour par: Envisioning Justice Solutions, Inc

Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations

This randomized controlled trial evaluates Exploring Trauma Plus (ET+), a brief, manualized, trauma-specific intervention designed for justice-involved men and transgender and gender-diverse individuals. The six-session curriculum uses psychoeducation, cognitive-behavioral strategies, mindfulness, grounding techniques, and structured exercises to help participants understand trauma, manage trauma-related distress, and develop coping skills.

The study is beging conducted at a California correctional facility for men and compares participants randomly assigned to ET+ with participants assigned to a waitlist control condition. The program is delivered by trained peer facilitators in general institutional housing on a custody level III yard.

Researchers assess changes in trauma-related distress, behavioral health symptoms, anger, and aggression using validated self-report measures administered before and after the intervention period.

Aperçu de l'étude

Description détaillée

The primary objective of the randomized controlled trial is to assess the effectiveness of the Exploring Trauma Plus (ET+) curriculum at reducing co-occurring trauma, anger, and aggression among men and the transgender and gender-diverse (TGD) community. Using a randomized experimental design, this study aims to quantitatively measure change on specifically targeted outcome measures over time spent in the ET+ program among a group of males and TGD individuals who participate in the program (treatment group) versus a group of similar males and TGD individuals who did not participate in the program (control group). Refined inferential statistical analyses will be employed to analyze the data collected and explore an integrated model of trajectories of trauma and aggression among participants in prison.

ET+ is a 6-week 6-session trauma-informed program that utilizes Peer Facilitators. Peer facilitators are individuals serving long-term sentences who volunteered for these positions and were specially trained to facilitate the program for other institutional residents who participate in the program.

Institutional Review Board (IRB) approval was received on May 23, 2024. CDCR Research Oversight Committee approvals and Data Sharing Agreements were sought and also approved. Oversight will continue throughout the duration of the study.

Researchers will use a randomization design to test the effectiveness of the ET+ curriculum to reduce trauma-related difficulties (i.e., mental health symptoms, trauma, anger, hostility and aggression) and to increase Restorative Justice outcome measures (i.e., resilience, social connectedness, empathy, and accountability for the harm that has been produced).

Measured outcomes will include PTSD symptoms (Trauma Symptoms Checklist [TSC-40] and the Short Screening Scale for DSM-IV PTSD), depression (Patient Health Questionnaire - Depression Subscale), anxiety (Patient Health Questionnaire - Anxiety), aggression (Buss-Warren Aggression Questionnaire), mental health functioning (K6 Brief Mental Health Screen), instrumental and expressive anger (Revised Instrumental and Expressive Representation Scales), the Brief Resilient Coping Scale, and the Dickman Impulsivity Scale.

Type d'étude

Interventionnel

Inscription (Estimé)

250

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • California
      • Corcoran, California, États-Unis, 93212
        • Recrutement
        • California State Prison, Corcoran
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria: All participants who expressed interest in participating in the study at the California men's prison and who were capable of providing written informed consent.

-

Exclusion Criteria: There were no study-defined exclusion criteria; operational exclusions or security restrictions were at the discretion of prison administration.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Exploring Trauma Plus Brief Intervention

This revised evidence-based six-session trauma intervention is designed for people who have experienced abuse and trauma. The understanding of gender has shifted from the binary male-female model to a more inclusive and expansive model. This second edition of Exploring Trauma is now entitled Exploring Trauma+: A Brief Intervention for Men and Gender-Diverse People in order to reflect the changes in this new edition. The definition of gender responsiveness has been expanded to include the experiences of transgender and nonbinary people. This new material has inclusive pronouns, as well as examples of traumatic events and focus questions specific to this group. The materials focus on the three core things that both staff and clients need: an understanding of what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships).

ET+ is an evidence-based 6-session brief intervention with a focus on trauma and PTSD, and techniques for Restorative Justice work with men (and those who identify as men). The rigorously evaluated manualized curriculum is designed for trauma treatment while emphasizing Restorative Justice principles and objectives, e.g., understanding victim impact, personal accountability, and restitution. The intervention is delivered to small groups of 10-12 men and co-led by two specially trained Peer Facilitators. Using a closed group model creates the experience of a prosocial support system based on a new value system and group agreements. This is strengthened by using Peer Facilitators as role models. The group process helps develop empathy and connectedness for other group members.

Aucune intervention: Waitlist Control Group

Participants assigned to the waitlist control condition, serving as the comparison group during the study. Participants are offered Exploring Trauma Plus (ET+) after their study participation.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Modified Short Screening Scale for DSM-IV PTSD (7-item symptom index, following a trauma-exposure screen)
Délai: Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.

The Modified Short Screening Scale for DSM-IV PTSD is a 7-item measure assessing the frequency of posttraumatic stress symptoms following exposure to a traumatic event. Items assess symptom frequency over the preceding four weeks, with responses ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.
Patient Health Questionnaire (PHQ) Anxiety Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire (PHQ) Anxiety Subscale is a 7-item measure assessing the frequency of anxiety symptoms over the preceding four weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score range is 0-18, with higher scores indicating greater anxiety symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
PHQ-9 Depression Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item measure assessing the frequency of depressive symptoms over the preceding two weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 composite score.
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Trauma Symptom Checklist-40 (TSC-40) is a 40-item measure assessing trauma-related symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). The composite score ranges from 0 to 120, with higher scores indicating greater trauma-related distress.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Anxiety Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Anxiety subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related anxiety symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater anxiety symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Depression Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Depression subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related depressive symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
TSC-40 Outcome Measures 1. Dissociation Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Dissociation subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 6 items assessing dissociative symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater dissociative symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 2. Sexual Abuse Trauma Index (SATI)
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sexual Abuse Trauma Index (SATI) of the TSC-40 consists of 7 items assessing symptoms associated with sexual abuse trauma over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 3. Sleep Disturbances Subscale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sleep Disturbances subscale of the TSC-40 consists of 6 items assessing sleep-related difficulties over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater sleep disturbance.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Buss-Warren Aggression Questionnaire (AQ)
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A measure of aggressive behavior and tendencies. ET+ uses only the Verbal Aggression and Physical Aggression subscales to assess verbal and physical expressions of aggression.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Brief Resilient Coping Scale
Délai: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A 4-item measure assessing the ability to cope with stress in an adaptive and resilient manner.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: NENA P Messina, Envisioning Justice Solutions, Inc

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 avril 2026

Achèvement primaire (Estimé)

30 juin 2028

Achèvement de l'étude (Estimé)

30 juin 2028

Dates d'inscription aux études

Première soumission

13 novembre 2026

Première soumission répondant aux critères de contrôle qualité

13 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared because sharing is subject to applicable data-use restrictions and authorization from the California Department of Corrections and Rehabilitation (CDCR).

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner